Skip to primary navigation
Skip to main content
Skip to footer

Exopharm

Home
Partnering
Investors
Contact
About Us
- Our Team
Press and Resource Centre
- Articles
- Understanding Exosomes

Exopharm Ltd — Refreshing Medicine, Today

Exopharm's mission is to be the global leader in exosome-based medicines.

Exopharm is an Australian regenerative medicine biopharmaceutical company that is seeking to develop and commercialise exosomes as therapeutic agents – initially a product called Plexaris™ and later a product called Cevaris™.

As key messengers within the human body, exosomes exert powerful effects on the actions and behaviours of existing cells. Recent research shows that exosomes are potent, broad-acting, and play essential roles in cellular activity, particularly tissue remodeling, inflammatory regulation and immuno-modulation, that affect the body's ability to repair itself.

Despite promise of administering exosomes as a cell-free treatment, the therapeutic exosome market has been held back by one key technological challenge: an efficient exosome extraction and purification process technology that would enable the manufacture of exosome-based medicines at clinical and then pharmaceutical grade and scale.

Exopharm's LEAP Technology provides a key step in the downstream manufacturing process to isolate and purify exosomes from a variety of cell sources, including platelets and adult stem cells. LEAP technology has provided access to high-purity exosomes that launched a virtuous circle of innovation at Exopharm, allowing it to solve other manufacturing and characterization challenges and to bring an exosome-based medicine into human clinical trials for the first time.

About Exopharm and the LEAP technology

Watch the below video explanation of Exopharm, the LEAP Technology and the Plexaris and Exomere products.

Ian Dixon features in Bio Insights: Exosomes as Next-Generation Cell-free Medicines

Ian Dixon features in Bio Insights: Exosomes as Next-Generation Cell-free Medicines

…read more →

Seeing Exosomes’ Potential To Treat Sensory Disability

Seeing Exosomes’ Potential To Treat Sensory Disability

…read more →

Exosomes: Nanoparticles full of Surprises

Exosomes: Nanoparticles full of Surprises

…read more →

Footer

Resources

ASX Announcements
Financial Reporting
Board of Directors
Press and Resource Centre

Information

Contact
Partnering
Join Our Mailing List
Privacy, Terms and Conditions

Search this website

Copyright © 2020 · Exopharm · ACN 163 765 991 · info@exopharm.com
Level 17/31 Queen St, Melbourne VIC Australia 3000 · P: +61 (0)3 9111 0026 ·

Web Design by Mallee Blue Media